{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:58:44Z","timestamp":1768899524371,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.atherosclerosis.2010.09.030","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T14:47:22Z","timestamp":1286808442000},"page":"449-457","source":"Crossref","is-referenced-by-count":24,"title":["Two adjacent domains (141\u2013150 and 151\u2013160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects"],"prefix":"10.1016","volume":"213","author":[{"given":"Gaurav","family":"Nayyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaila P.","family":"Handattu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candyce E.","family":"Monroe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjula","family":"Chaddha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara D.","family":"Keenum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayakonda N.","family":"Palgunachari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Anantharamaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0005","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1073\/pnas.89.10.4471","article-title":"Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells","volume":"89","author":"Piedrahita","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0015","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1172\/JCI116091","article-title":"Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B","volume":"90","author":"Shimano","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0020","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1172\/JCI114126","article-title":"Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits","volume":"83","author":"Mahley","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0025","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/01.CIR.0000038419.53000.D6","article-title":"Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy","volume":"106","author":"Grundy","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","article-title":"Apolipoprotein E: structure\u2013function relationships","volume":"45","author":"Weisgraber","year":"1994","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0040","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0006-291X(82)91927-1","article-title":"Apolipoprotein E degradation in human very low density lipoproteins by protease(s): chemical and biological consequences","volume":"109","author":"Bradley","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/bi991209w","article-title":"The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts","volume":"39","author":"Datta","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0050","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1016\/S0021-9258(17)39238-4","article-title":"Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine","volume":"260","author":"Anantharamaiah","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0055","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0022-2275(20)31620-5","article-title":"Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo","volume":"42","author":"Datta","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(03)00101-1","article-title":"Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice","volume":"168","author":"Garber","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0065","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1161\/CIRCULATIONAHA.104.497107","article-title":"Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits","volume":"111","author":"Gupta","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2009.07.019","article-title":"Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2","volume":"208","author":"Datta","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0006-291X(86)80489-2","article-title":"Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains","volume":"134","author":"Cardin","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.ATV.16.2.328","article-title":"Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity: implications for HDL assembly","volume":"16","author":"Palgunachari","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0085","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/bi00731a008","article-title":"Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine","volume":"12","author":"Morrisett","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0076-6879(86)28066-0","article-title":"Sequential flotation ultracentrifugation","volume":"128","author":"Schumaker","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0095","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1074\/jbc.M606231200","article-title":"ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers","volume":"282","author":"Handattu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0076-6879(83)98152-1","article-title":"Receptor-mediated endocytosis of low-density lipoprotein in cultured cells","volume":"98","author":"Goldstein","year":"1983","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-2275(20)38354-1","article-title":"A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent","volume":"30","author":"El-Saadani","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-2275(20)39892-8","article-title":"Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans","volume":"36","author":"Ji","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)31163-9","article-title":"A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis","volume":"42","author":"Garber","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.ATV.14.4.605","article-title":"ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum","volume":"14","author":"Palinski","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0076-6879(86)28096-9","article-title":"Synthetic peptide analogs of apolipoproteins","volume":"128","author":"Anantharamaiah","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0065-3233(08)60643-9","article-title":"The amphipathic \u03b1 helix: a multifunctional structural motif in plasma apolipoproteins","volume":"45","author":"Segrest","year":"1994","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0140","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0022-2275(20)31599-6","article-title":"Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide","volume":"42","author":"Datta","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0145","doi-asserted-by":"crossref","first-page":"26509","DOI":"10.1074\/jbc.M314276200","article-title":"Aromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activity","volume":"279","author":"Datta","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.mol.0000226114.89812.75","article-title":"Synthetic peptides: managing lipid disorders","volume":"17","author":"Anantharamaiah","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2010.09.030_bib0155","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1194\/jlr.R700010-JLR200","article-title":"Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides","volume":"48","author":"Anantharamaiah","year":"2007","journal-title":"J Lipid Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010008087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010008087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T17:13:43Z","timestamp":1636650823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010008087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0021915010008087"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.09.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}